pkc activity assays Search Results


p66 10g  (Sino Biological)
90
Sino Biological p66 10g
P66 10g, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p66 10g/product/Sino Biological
Average 90 stars, based on 1 article reviews
p66 10g - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pkc lipid activator  (Sino Biological)
91
Sino Biological pkc lipid activator
Pkc Lipid Activator, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkc lipid activator/product/Sino Biological
Average 91 stars, based on 1 article reviews
pkc lipid activator - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
pkc alpha  (Sino Biological)
93
Sino Biological pkc alpha
Pkc Alpha, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkc alpha/product/Sino Biological
Average 93 stars, based on 1 article reviews
pkc alpha - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
pkc δ  (R&D Systems)
90
R&D Systems pkc δ
Pkc δ, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkc δ/product/R&D Systems
Average 90 stars, based on 1 article reviews
pkc δ - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
active signalchem p64 10g 10 pkc alpha  (Sino Biological)
90
Sino Biological active signalchem p64 10g 10 pkc alpha
Active Signalchem P64 10g 10 Pkc Alpha, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/active signalchem p64 10g 10 pkc alpha/product/Sino Biological
Average 90 stars, based on 1 article reviews
active signalchem p64 10g 10 pkc alpha - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
vitro pkcα kinase assay  (Sino Biological)
92
Sino Biological vitro pkcα kinase assay
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Vitro Pkcα Kinase Assay, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vitro pkcα kinase assay/product/Sino Biological
Average 92 stars, based on 1 article reviews
vitro pkcα kinase assay - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
p75 10g  (Sino Biological)
92
Sino Biological p75 10g
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
P75 10g, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p75 10g/product/Sino Biological
Average 92 stars, based on 1 article reviews
p75 10g - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
pkc  (Sino Biological)
93
Sino Biological pkc
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Pkc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkc/product/Sino Biological
Average 93 stars, based on 1 article reviews
pkc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
gst  (SignalChem)
93
SignalChem gst
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Gst, supplied by SignalChem, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst/product/SignalChem
Average 93 stars, based on 1 article reviews
gst - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
pkd2  (Sino Biological)
90
Sino Biological pkd2
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Pkd2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkd2/product/Sino Biological
Average 90 stars, based on 1 article reviews
pkd2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
active rhpkc  (Sino Biological)
90
Sino Biological active rhpkc
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Active Rhpkc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/active rhpkc/product/Sino Biological
Average 90 stars, based on 1 article reviews
active rhpkc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pkcα  (Sino Biological)
90
Sino Biological pkcα
Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by <t>PKC</t> α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP <t>or</t> <t>GST</t> ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).
Pkcα, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pkcα/product/Sino Biological
Average 90 stars, based on 1 article reviews
pkcα - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by PKC α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP or GST ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).

Journal: FEBS Open Bio

Article Title: Protein kinase C regulates AMPA receptor auxiliary protein Shisa9/ CKAMP 44 through interactions with neuronal scaffold PICK 1

doi: 10.1002/2211-5463.12261

Figure Lengend Snippet: Shisa9/ CKAMP 44 interacts with PICK 1 and is phosphorylated by PKC α. (A) Schematic overview of Shisa9/ CKAMP 44 constructs used in this study (including the location of the respective tag): in CKAMP 44‐ FL (full length), the tag is C‐terminal to the signal peptide in the extracellular domain ( TM , yellow). Constructs with only the cytoplasmic tail of Shisa9/ CKAMP 44 are N‐terminally tagged (with either EGFP or GST ). PDZ ligand sequences are shown in red and are deleted in constructs labelled with ΔC ( PDZ ‐binding‐deficient variant). A conserved region of Shisa9/ CKAMP 44 (blue; N‐terminal region of the cytoplasmic tail) is deleted in the construct CKAMP 44‐ΔNΔC. Constructs are drawn to scale. (B) Comparative coimmunoprecipitation experiments of PICK 1 ( FLAG ‐ PICK 1) with Shisa9/ CKAMP 44 C‐terminal variants EGFP ‐ CKAMP 44, −ΔC, or −ΔNΔC). Proteins were precipitated using GFP antibody or mIgG (negative control) and detected using the antibodies indicated. Inputs are shown on the left. (C) Full‐length Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ), expressed in COS ‐7 cells, is phosphorylated following induction by PMA (1 μ m , 30 min). Phosphorylated proteins (indicated) are separated from nonphosphorylated proteins (indicated) via Phos‐tag‐ SDS / PAGE and observed via WB; phosphatase treatment with alkaline phosphatase is used as a negative control, thereby highlighting the phosphorylation dependence of the mobility shift. (D) Phosphorylation of Shisa9/ CKAMP 44 ( FLAG ‐ CKAMP 44‐ FL ) is induced with PMA and inhibited by application of the PKC inhibitor GF 109203X in COS ‐7 cells. Again phosphorylated proteins are observable via Phos‐tag‐ SDS / PAGE . PKC inhibitor concentrations are indicated above. (E) An in vitro PKC α kinase assay followed by Phos‐tag SDS / PAGE analysis highlights a PKC α‐dependent mobility shift of the phosphorylated substrate GST ‐ CKAMP 44 (top panel, Phos‐tag SDS / PAGE ). Presence of PKC α and kinase substrate present in the same samples is shown below (lower panel, standard Laemmli SDS / PAGE and WB; antibodies indicated).

Article Snippet: Purified and desalted GST‐CKAMP44 protein was used for an in vitro PKCα kinase assay (SignalChem, Richmond, Canada; #P61–18G) according to the manufacturer's instructions.

Techniques: Construct, Binding Assay, Variant Assay, Negative Control, SDS Page, Phospho-proteomics, Mobility Shift, In Vitro, Kinase Assay